Commercialization is a pivotal step in translating research innovations into real-world solutions that can save lives. For military medical research, the stakes are even higher, as these advancements directly impact the health and readiness of service members. Geneva is uniquely positioned to guide researchers through this complex journey, offering comprehensive expertise to accelerate the transition from innovation to implementation.

Geneva offers comprehensive expertise to accelerate the commercialization of research innovations and knowledge products for both military and civilian sectors. Introducing a new product or production method into the market is a complex process, but Geneva’s experienced team excels in navigating these challenges in collaboration with research and development teams.

A Collaborative Approach

Geneva bridges the gap between industry, academia, government, and non-profit stakeholders, fostering cross-functional engagement to align innovation with market needs. Our collaborative approach fosters partnerships across industry, academia, government, and nonprofits to drive impactful solutions to unmet clinical needs.

Intellectual Property (IP) Management

Geneva provides end-to-end IP management expertise to protect and maximize the value of research innovations and technologies:

- Patentability assessment and patent application submission
- Portfolio management and licensing strategies
- Technology transfer agreements and strategic commercialization planning

FDA Regulatory Pathway & Submission Strategy

Geneva provides expert guidance and strategic planning to navigate the complex FDA regulatory landscape:

- Investigational Device Exemption (IDE) applications
- Premarket Approvals (PMA) and Premarket Notifications (510(k))
- Strategic planning to streamline the approval process
- Ensuring compliance to meet stringent regulatory requirements